drugset / Trial / NCT00673244

Protocol to Assess the Severity of Acute Kidney Injury

NCT00673244

Completed 77 enrolled George Washington University
NaSingle-groupOpen-labelPrevention

Summary

The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict the course of AKI (recovery v. RRT v. death)

Timeline

Start
2008-04
Primary completion
2013-12
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 1 mg/kg Intravenous
Subject Furosemide Other / unclassified 1.5 mg/kg Intravenous

Indications